DAFTAR PUSTAKA
Ahmad, M.R. and Pervaiz, M.K., 2011. Cigarette Smoking and Risk of Bladder
Cancer, A Meta Analysis. Pakistan Journal of Medicine Research, vol. 50, no.
2, p. 88-92.
Alberg, A.J. and Hébert, J.R., 2009. Cigarette Smoking and Bladder Cancer: A New
Twist in an Old Saga?. Journal of the National Cancer Institute, vol. 101, no.
22, p. 1525-1526.
American Cancer Society, 2014. Bladder Cancer. American Cancer Society.
Available from: http://www.cancer.org/acs/groups/cid/documents/webcontent
/003085-pdf.pdf [Accessed 11 April 2015].
American Joint Committee on Cancer, 2010. AJCC Cancer Staging Manual 7th ed.. New York: Springer, p. 497-502.
Anastasiou, I., Mygdalis, V., Mihalakis, A. et al., 2009. Patient Awareness of
Smoking as A Risk Factor for Bladder Cancer. International Urology and
Nephrology, vol. 42, no. 2, p. 309-314.
Barrett, K.E., Barman, S.M., Boitano, S. and Brooks, H.L., 2012. Ganong’s Review
of Medical Physiology 24th ed.. USA: Mc Graw-Hill, p. 693-695.
Bladder Cancer Advocacy Network, 2008. Bladder Cancer Basics for the Newly
Diagnosed. Bladder Cancer Advocacy Network. Available from:
http://urology.ucla.edu/workfiles/Bladder_Cancer/Bladder_Cancer_Basics_fo
r_the_Newly_Diagnosed.pdf [Accessed 08 April 2015].
Colombel, M., Soloway, M., Akaza, H. et al., 2008. Epidemiology, staging, grading
& risk stratification of bladder cancer. European Urology Supplements, vol.
7, no. 10, p. 618-626.
Drake, R.L., Vogl, W. and Mitchell, A.W.M., 2012. Gray’s Basic Anatomy.
Philadelphia: Elsevier, p. 221-223.
Eroschenko, V.P., 2012. Atlas Histologi diFiore dengan Korelasi Fungsional.
Jakarta: EGC, p. 388-391.
Feng, Z., Hu, W., Rom, W.N., Beland, F.A., and Tang, M., 2002. 4-Aminobiphenyl
binding spectrum in human p53 gene. Carcinogenesis, vol. 23, no. 10, p.
1721-1727.
Freedman, N.D., Silverman, D.T.S., Hollenbeck, A.R. et al., 2011. Association
Between Smoking and Risk of Bladder Cancer Among Men and Women. The
Journal of the American Medical Association, vol. 306, no. 7, p. 737-745.
Gu, J., Horikawa, Y., Chen, M. et al., 2008. Benzo(a)pyrene Diol Epoxide-Induced
Chomosome 9p21 Aberrations Are Associated with Increased Risk of Bladder
Cancer. Cancer Epidemiology Biomarkers and Prevention, vol. 17, no. 9, p.
2445-2450.
Jiang, X., Castelao, J.E., Yuan, J.M. et al., 2012. Cigarette Smoking and Subtypes
of Bladder Cancer. International Journal of Cancer, Vol. 130, no. 4, p.
896-901.
Jung, I. and Messing, E., 2000. Molecular Mechanisms and Pathways in Bladder
Cancer Development and Progression. Cancer Control, vol. 7, no. 4, p.
325-334.
Kementrian Kesehatan Republik Indonesia, 2013. Riset kesehatan dasar
(Riskesdas). Direktorat Jenderal Kesehatan Republik Indonesia. Badan
Penelitian dan Pengembangan Kesehatan, Jakarta.
Kementrian Kesehatan Republik Indonesia, 2015. Info Datin Kanker Indonesia.
Sekretariat Jenderal Kementrian Kesehatan Republik Indonesia, Pusat Data
dan Informasi Kementrian Kesehatan Republik Indonesia.
Konety, B.R. and Carroll, P.R., 2013. Urothelial Carcinoma: Cancers of the
Bladder, Ureter, & Renal Pelvis. In: McAninch, J.W. and Lue, T.F., eds. Smith
& Tanagho’s General Urology, 18th ed.. USA: Mc Graw-Hill, p. 310-322. Konety, B.R. and Joslyn S.A., 2003. Factors influencing aggressive therapy for
bladder cancer: an analysis of data from the SEER program. Journal of
Urology, vol. 170, p. 1765-1771.
Lifestyle Statistics Team, Health and Social Care Information Centre, 2014.
Statistic on Smoking, England 2014. Health and Social Care Information
Mescher, A.L., 2013. Junqueira’s Basic Histology Text and Atlas 13th ed.. USA: Mc Graw-Hill Education, p. 398-401.
Mitra, A.P. and Cote, R.J., 2009. Molecular Pathogenesis and Diagnostics of
Bladder Cancer. The Annual Review of Pathology: Mechanism of Disease,
vol. 4, p. 251-285.
National Cancer Institute, 2010. What You Need To Know AboutTM Bladder Cancer. U.S. Department of Health and Human Services. National Institute of Health.
National Cancer Institute, 2015. Surveillance, Epidemiology, and End Results
Program (SEER) Stat Fact Sheets: Bladder Cancer. U.S. Department of Health
and Human Services. National Institute of Health. Available from:
http://seer.cancer.gov/statfacts/html/urinb.html [Accessed 25 April 2015].
National Comprehensive Cancer Network, 2014. NCCN Clinical Practice
Guidelines in Oncology Bladder Cancer Version 2.2014. National
Comprehensive Cancer Network.
Pakzad, R., Hafshejani, A.M., Mohammadian, M. et al., 2015. Incidence and
Mortality of Bladder Cancer and their Relationship with Development in Asia.
Asian Pacific Journal of Cancer Prevention, vol. 16, p. 7365-7374.
Pasin, E., Josephson, D.Y., Mitra, A.P. et al., 2008. Superficial Bladder Cancer:
An Update on Etiology, Molecular Development, Classification, and Natural
History. Reviews in Urology, vol. 10, no. 1, p. 31-43.
Pietzak, E.J. and Malkowicz, S.B., 2014. Does Quantification of Smoking History
Correlate with Initial Bladder Tumor Grade and Stage?. Current Urology
Report, vol. 15, ed. 7, p. 416.
Pietzak, E.J., Mucksavage, P., Guzzo, T.J. et al., 2015. Heavy Cigarette Smoking
and Aggressive Bladder Cancer at Initial Presentation. Urology, vol. 86, p.
968-973.
Pietzak, E.J., Mucksavage, P., Guzzo, T.J., and Malkowicz, S.B., 2013. Heavy
Cigarette Smoking is Associated with More Aggressive Bladder Cancer at
Prout, G.R. Jr., Wesley, M.N., Yancik, R. et al., 2005. Age and comorbidity impact
surgical therapy in older bladder carcinoma patients: a population-based
study. Cancer, vol. 104, no. 8, p. 1638-1647.
Quirk, J.T., Li, Q., Natarajan, N. et al., 2004. Cigarette Smoking and the Risk of
Bladder Cancer in Men and Women. Tobacco Induced Diseases, vol. 2, no.3,
p. 141-144.
Rink, M., Furberg, H., Zabor, E.C. et al., 2013. Impact of Smoking and Smoking
Cessation on Oncologic Outcomes in Primary Non-muscle-invasive Bladder
Cancer. European Urology Journal, vol. 63, no. 4, p. 724-732.
Sherwood, L., 2011. Fisiologi Manusia: Dari Sel ke Sistem, Edisi 6. Jakarta: EGC,
p. 595-597.
Shim, U.J., Lee, I.S., Kang, H.W., Kim, J. et al., 2013. Decreased DBC1 Expression
Is Associated With Poor Prognosis in Patients With Non-Muscle-Invasive
Bladder Cancer. Korean Journal of Urology, vol. 54, p. 631-637.
Sievert, K.D., Amend, B., Nagele, U. et al., 2009. Economic aspects of bladder
cancer: what are the benefits and costs?. World Journal of Urology, vol. 27,
no. 3 , p. 295-300.
Supit, W., Mochtar, C.A., Sugiono, M. et al., 2011. Survival of Patients with
Transitional Cell Carcinoma of the Urinary Bladder in Indonesia: A Single
Institution Review. Asian Pacific Journal of Cancer Prevention, vol. 12, p.
549-553.
Syvänen, K.T., Järveläinen, H., Taimen, P. et al., 2014. Neoadjuvant Chemotherapy
in Muscle-Invasive Bladder Cancer. European Medical Journal.
Tanagho, E.A. and Lue, T.F., 2013. Anatomy of Genitourinary Tract. In:
McAninch, J.W. and Lue, T.F., eds. Smith & Tanagho’s General Urology, 18th ed.. USA: Mc Graw-Hill, p. 7-8.
Taylor, J.A. and Kuchel, G.A., 2009. Bladder cancer in the elderly: clinical
outcomes, basic mechanisms, and future research direction. Nature Clinical
Pratice Urology, vol. 6, no. 3, p. 135-144.
Tiera, H. dan Umbas, R., 2013. Pemeriksaan Rapid Urinary Bladder Cancer:
Indonesia (Penelitian awal). Indonesian Journal of Cancer, vol. 7, no. 2, p.
41-46.
U.S. Department of Health and Human Services, 2010. A Report of the Surgeon
General: How Tobacco Smoke Causes Disease. U.S. Department of Health and
Human Services, Centers for Disease Control and Prevention, National Center
for Chronic Disease Prevention and Health Promotion, Office on Smoking and
Health.
Wahyuni, A.R., 2007. Statistika Kedokteran (disertai aplikasi dengan SPSS).
Jakarta: Bamboedoea Communication, p. 8-9.
Wallerand, H., Bakkar, A.A., Medina, S.G., Pairon, J.C. et al., 2005. Mutations in
TP53, but not FGFR3, in urothelial cell carcinoma of the bladder are
influenced by smoking: contribution of exogenous versus carcinogens.
Carcinogenesis, vol. 26, no. 1, p. 177-184.
Warli, S.M., Umbas, R., Hardjowijoto, S. et al., 2014. Panduan Penanganan
Kanker Kandung Kemih Tipe Urotelial. Ikatan Ahli Urologi Indonesia.
WHO, 2012. GLOBOCAN: Estimated incidence, mortality and 5-year prevalence:
both sexes. Available from: http://globocan.iarc.fr/old/factsheet.asp [Accessed
11 April 2015].
Xue, J., Yang, S., and Seng, S., 2014. Mechanisms of Cancer Induction by
Tobacco-specific NNK and NNN. Multidisciplinary Digital Publishing Institute, vol. 6,
